Osteoporosis and fragility fractures have been regarded as important public health concerns. We investigated their possible association with vitamin D receptor (VDR) FOK1 polymorphisms (rs10735810) and dietary parameters such as calcium and vitamin D intake. A total of 264 Iranian obese women (BMI.30 kg/m 2 ) were categorized based on the FOK1 genotype and divided into two groups: group one with the FF genotype (n5184) and the f allele carrier group with the Ff or ff genotype (n580). The body composition, dietary intake and bone mineral density were assessed for all cases. The frequency of the F and f alleles for FOK1 in the study were 71.5% and 28.5%, respectively. Women with the f allele had a higher BMI (p50.05), as well as parathyroid hormone (PTH) and tumor necrosis factor alpha (TNF-a) concentration (p50.05, p50.01, respectively). Participants with calcium intakes of more than 1,000 mg/d and the ff genotype had a higher L2_L4 Z-score. Moreover, women with vitamin D intakes of less than 600 IU/d and the ff genotype had a higher total T-score and total Z-score. Although women whose dietary intake of vitamin D was higher than the recommended dietary allowance (RDA.600 IU/d) and had the FF genotype had a higher total T-score and total Z-score, as well. Our findings suggest that interactions between FOK1 polymorphisms in Iranian obese women and dietary intake of calcium and vitamin D may play a decisive role in bone mineral density and osteoporosis among these women.
Osteoporosis has been termed a "silent disease" because it progresses without symptoms until a fracture occurs. The fractures caused by osteoporosis have a great impact on public health, as they are often associated with increased morbidity, mortality, reduced quality of life, long hospital stays and high economic cost (1) . Consequently, cost-effective intervention policies must urgently be identified in an attempt to minimize the impact of fractures (2) . Osteoporosis has been associated with various risk factors, particularly female gender (3), advanced age (4), dietary calcium (5) , vitamin D status (6) , obesity (7) , chronic obstructive pulmonary disease (COPD) (8) , stress (9) , gastric bypass surgery (10, 11) , genetic variants (12) (13) (14) , alcoholism (15) and smoking habit (16) .
Calcium and vitamin D intake, as the preventive nutritional treatment of osteoporosis, plays an important role in improving health status (17, 18) . Factors such as living in an urban area with no or low exposure to direct sunlight, as well as inadequate dietary intake of vitamin D lead, to a decrease in BMD (19) . However, concern over increased risk of melanoma with unprotected sunlight (Ultraviolet B) exposure has led to the alternative recommendation that sufficient vitamin D should be supplied through dietary sources alone (20) .
BMD is under strong genetic control. Some studies which were conducted on Caucasian and Asian women suggest that polymorphisms in the vitamin D receptor (VDR) gene are associated with BMD in postmenopausal women (21) . VDR modulation influences the expression and transcription of genes which are involved in bone mass formation and calcium uptake, such as osteocalcin and calcium-binding proteins (22) . Polymorphism of the VDR gene alleles may account for the major part of the heritable component of bone density in women, possibly mediated in part by impaired calcium absorption from the bowel (1) .
The VDR FOK1 polymorphism corresponds to a single strand conformation polymorphism (M and m alleles) with the M and f alleles being equivalent. Significant associations of this polymorphism with low BMD have been described in some studies of adults but not in others (23) . However, Arai et al. (24) suggested that this polymorphism had an effect in younger Japanese women.
Although major risk factors have been identified, genetic variants and heredity factors, specifically polymorphic variants of the VDR gene, represent an important understudied area in osteoporosis research. Population studies of vitamin D intake have produced conflicting results, which may be due to FOK1 polymorphic variants of the VDR gene. Hence, our study aimed to investigate the association between vitamin D intakes with VDR gene FOK1 polymorphisms (rs10735810).
SUBJECTS
The current cross-sectional study included 264 Iranian obese women (BMI.30 kg/m 2 ) who underwent anthropometric assessments as well as blood collection between January 2013 and March 2013 (for equal sun exposure in winter) at the endocrine clinic of Shariati Hospital. For all participants, body weight (BW) and body height (BH) were measured to determine the BMI, calculated as BMI5BW (kg)/BH (m) 2 . The minimum, maximum, and mean BMI measurements for the 264 participants were 30, 46.9, and 35.3 kg/m 2 , respectively. Body composition was measured using a body composition analyzer. We divided the total participants according to FOK1 genotype (rs10735810) into two groups: group one with the FF genotype (n5184) and group two or the f allele carrier group with the Ff or ff genotype (n580).
METHODS
The protocol of the study was approved by the local ethics committee of Tehran University of Medical Sciences (Ethic number: 90-03-27-14619). The study participants were chosen according to our defined inclusion criteria, namely an age of 17-69 y, absence of any acute or chronic disease, no alcohol or drug abuse, and not being pregnant. Each participant was provided with a written and informed consent form before taking part in the study.
Single nucleotide polymorphism (SNP) genotyping. About 4 mL aliquots of peripheral blood samples were collected from each participant and stored in ethylenediaminetetraacetic acid (EDTA)-coated vacutainers. Genomic DNA was isolated from peripheral blood leukocytes according to standard methods which were previously described (25, 26) . The FOK1 polymorphism (rs10735810) of the VDR gene was detected by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. PCR was performed to amplify target regions of DNA. The amplification conditions were as follows: an initial denaturation at 94˚C for 5 min, followed by 35 amplification cycles (denaturation at 94˚C for 15 s, annealing at 60˚C for 30 s, and extension at 72˚C for 30 s) and a final extension at 72˚C for 10 min. PCR products were digested with FOK1 (Boehringer Mannheim) for 1.5-2 h at 37˚C. The digested PCR products were resolved on 2.0% agarose gels. For FOK1 polymorphism (rs10735810) sited in the VDR gene that alters the first start codon and three polymorphisms in the in 3′ untranslated region, the f genotype was indicated by the presence of the restriction site that generates two fragments of 196 bp and 69 bp and the F genotype by a single uncleaved 265bp fragment. To confirm the accuracy of genotyping, partial samples (20% of all samples) were examined by DNA sequencing.
Biochemical, hormonal and serum cytokines concentration assay. All baseline blood samples were collected between 8:00 and 10:00 am following an overnight fast. The serum samples were centrifuged and the aliquots stored at a temperature of 280˚C until they were assayed. All samples were analyzed through a single assay technique. All measurements were performed at the Endocrinology and Metabolism Research Institute (EMRI) Bionanotechnology Laboratory of Tehran University of Medical Science.
Complete body composition analysis. The body composition of all cases was assessed with the use of Body Composition Analyzer BC-418MA-Tanita (United Kingdom) by strictly following the techniques, procedure, and precaution of the manufacturer's protocol (27) . The device calculates body composition parameters on the basis of data obtained by dual energy X-ray absorptiometry (DXA) using bioelectrical impedance analysis (BIA).
Dietary intake measurement. Daily dietary intake was assessed using a three-day dietary recall (3DR). The participants were instructed to complete a 3-nonconsecutive-day food record, with two days being on the weekend. After obtaining the 3DR record, a professional nutritionist analyzed the data and checked for further clarifications about the food consumption and quantities. Analysis of the data was done to obtain information concerning the intake of macronutrients, minerals and vitamins. It also yielded information regarding dietary intake.
Bone mineral density measurement. BMD was measured by DXA using the Lunar DPX-MD device (Lunar Corporation, Madison, WI). The DXA device was calibrated daily and weekly by using appropriate phantom methods. To assess BMD, measurements of the second to fourth lumbar vertebrae and the femur bone (neck, trochanter and the whole femur) were used. Bone density was calculated based on g/cm 2 .
Statistical analyses. Statistical analysis was performed using SPSS version 22.0 (SPSS, Chicago, IL). The Hardy-Weinberg equilibrium and comparison of categorical variables were assessed using the chi-square test. All dietary intake was reported in the tables by the energy adjusted residual model and used in the linear regression model. Descriptive statistics including the mean (standard deviation) and frequency summary statistics were used to describe the study population. Comparisons between the two groups were made using the independent t-test for continuous variables and chi-square test to investigate categorical variables.
Moreover, age and energy intake-adjusted analyses were performed in general linear models. Furthermore, to analyze the potential interactions between genotype and diet intake, after entering the genotype and vitamin D as well as calcium intake, an interaction term of geno-type3calcium or vitamin D dietary intake on bone characteristics was included in the general linear models. All reported p-values were two-sided and a p-value of 0.05 was considered as statistically significant. 
RESULTS

Study population characteristics
The mean age, height, weight and BMI of the study participants was 39.12 (SD 11.78) y, 159.33 (SD 6.40) cm, 88.64 (SD 12.71) kg and 35.03 (SD 4.25) kg/m 2 , respectively. The allele frequency for FOK1 (rs10735810) in the study was F 71.5% and f 28.5%. Moreover overall prevalence of FOK1 genotypes was FF 69%, Ff 21% and ff 9% ( Table 1) .
A total of 264 Iranian obese women were categorized based on the FOK1 genotype and divided into two groups: group one with the FF genotype (n5184) and the f allele carrier group with the Ff or ff genotype (n580) ( Table  2 ). An independent t-test was employed to assess the differences in fat percentage, FFM, FM and BMI between the first group with the FF genotype and the second or f allele carrier group. The result of the study revealed that there was a statistically significant difference in age (p50.008), weight (p50.01), BMI (p50.0005), total body weight (TBW) (p50.01), visceral fat (p50.0005), fasting blood sugar (FBS) (p50.01), PTH (p,0.0001), TNF-a (p50.0004), interleukin-6 (IL-6) (p,0.0001), L2_L4 BMD (p,0.0001), L2_L4 T-score (p,0.0001), L2_L4 Z-score (p,0.0001), total BMD (p50.0004), total T-score (p50.001) and total Z-score (p50.003) between the two groups. However, no significant difference was observed regarding height, fat percentage, fat mass, trunk fat, TG, cholesterol, HDL-C, LDL-C, LDL-ox, vitamin D, insulin, hs-CRP, IL-4 or cross laps between the two groups (p.0.05). However, after adjustment for age only BMI (p50.05), PTH (p50.05), TNF-a (p50.01), L2_L4 BMD (p50.01), L2_L4 T-score (p50.009), L2_L4 Z-score (p50.004), total BMD (p50.03), total T-score (p50.03) and total Z-score (p50.02) maintained their significant differences.
Dietary intake
A three-day 24-h dietary recall was employed to measure dietary intake. Before accounting for calorie intake, there was significant difference in carbohydrate (p50.03), fat (p50.003), fiber (p,0.0001), calcium (p50.01), phosphorus (p50.02), iron (p,0.001), magnesium (p50.002), potassium (p50.001), zinc (p,0.001), chromium (p,0.001), molybdenum (p50.007), vitamin A (p50.07), vitamin E (p,0.001), vitamin D (p,0.001), and vitamin B2 (p50.01). But, after factoring in energy intake, FOK1 genotypes showed significant effect on oleic acid (p50.01), vitamin B6 (p50.04), and vitamin E (p50.03) between the two groups ( Table 3) .
Gene by diet interactions on bone characteristics
In the general linear model (GLM) analysis by dietary factors, calcium and vitamin D intake modified the interactions between FOK1 polymorphism (rs10735810) of the VDR and bone characteristics.
Women whose dietary calcium intake was less than the recommended dietary allowance (RDA,1,000 mg/d) had no significant difference regarding bone characteristics-in particular BMD, T-score and Z-score (p.0.05)-compared to those with a calcium intake higher than the recommended dietary allowance (RDA.1,000 mg/d). However after the FOK1 genotype was added as a covariate in the model, women with calcium intakes of more than 1,000 mg/d and the ff genotype had a higher L2_L4 Z-score (p Interaction50.03. However, women with calcium intakes of less than 1,000 mg/d and the FF genotype had a higher L2_L4 Z-score (p Interaction50.03) (Fig. 1) .
We also tested interactions between FOK1 genotypes and vitamin D intake. Obese women with vitamin D intakes of less than the recommended dietary allowance (RDA,600 IU/d) had a lower total T-score (p50.002) as well as total Z-score (p50.001). However, after the FOK1 genotype was added as a covariate in the model, women with vitamin D intakes of less than 600 IU/d and the ff genotype had a higher total T-score (p Interaction50.008) and total Z-score (p Interaction50.007). However, women with a vitamin D intake higher than the recommended dietary allowance (RDA.600 IU/d) and the FF genotype had a higher total T-score (p Interaction50.008) and total Z-score, as well (p Interaction50.007) (Fig. 2) . We had just 37 postmenopausal women; they interfered in our analysis and adjustment, but we did not find any significant correlation with other variables.
DISCUSSION
Osteoporosis and fragility fractures have been considered as important public health issues (28) . In an effort to identify factors responsible for susceptibility to low BMD in Iranian women we investigated its possible association with FOK1 polymorphisms (rs10735810) and dietary parameters, particularly calcium and vitamin D intake.
In the present study we found that both f and F genotypes of FOK1 polymorphisms (rs10735810) were common in Iranian women. The gene frequency of the f allele was 28.5%. The genotype frequencies of FF, Ff and ff were 69%, 21% and 9%, respectively. The f allele frequency of the Iranian women was approximately the same as that of global minor allelic frequency (29) .
After adjustment for age, our findings demonstrated that the bone parameters were positively associated with the FF genotype of FOK1 polymorphisms. To illustrate, the f allele carrier group (Ff and ff genotypes) had a lower L2_L4 BMD, L2_L4 T-score, L2_L4 Z-score, total BMD, and total T-score as well as total Z-score. As indicated above, the f allele of the VDR FOK1 gene is an important risk factor for low BMD (30) and osteoporosis (31, 32) and seems to directly affect bone mineral mass in women. The results are in line with previous similar studies conducted in Iran, Japan, India and Korea, where FOK1 polymorphism was significantly correlated with bone mineral mass (24, 31, (33) (34) (35) (36) . In contrast, in Irish and Taiwanian studies, FOK1 did not significantly influence BMD or bone turnover (37, 38) . Furthermore, our study found no significant difference in cross laps bone turnover marker between the two groups of FOK1 genotypes; however, another study on Iranian women reported that participants with the ff genotype had higher serum cross laps (33) .
In the current study the f allele carrier group had a higher BMI, as well as serum levels of PTH and TNFa. Similarly, Žofková et al. (39) , suggested that FOK1 polymorphism of the VDR gene is closely related to the magnitude of PTH secretion and/or degradation in postmenopausal women. Moreover, Hossein-nezhad et al. (33) observed that carriers of the f allele had higher serum levels of TNF-a. According to other studies, BMDs were inversely correlated with fat mass (40), serum concentrations of TNF-a (33) and PTH (41) . Therefore, part of the lower bone parameters in the f allele carrier group may be a result of higher BMI, TNF-a and PTH.
Our study revealed that after adjustment for energy intake, age and weight; FOK1 polymorphism (rs10735810) had a weak association with phosphorus, and had no significant effect on macronutrient, mineral or vitamin intake.
Our study also suggests that there is an interaction effect between calcium and vitamin D intake with FOK1 genotypes. Women with calcium intakes of more than 1,000 mg/d and the ff genotype had a higher L2_L4 Z-score ( Fig. 1, C chart) . Indeed, the participants with the ff genotype were more vulnerable to calcium deficiency, as shown in a lower L2-L4 Z-score. On the other hand, women with sufficient calcium intakes had higher L2_L4 Z-scores. Moreover, Yu et al. (42) indicated that Chinese women with the FF genotype regained more BMD after calcium supplementation. According to experimental studies, FOK1 can significantly affect the whole body BMD in those with a Ca intake.800 mg/d, while for those with a Ca intake800 mg/d, the FOK1 genotype did not have a significant effect on whole body BMD (43) . Our evidence suggested that women with vitamin D intakes of less than 600 IU/d and the ff genotype had a higher total T-score and total Z-score, although, women with a vitamin D intake of more than the recommended dietary allowance (RDA.600 IU/d) and the FF genotype had a higher total T-score and total Z-score (Fig. 2 , E and F charts). In line with our findings, a recent study of Sanwalka et al. (44) reported that women with the FF genotype displayed vitamin D levels and had higher bone quality, after an independent sample t-test. We found similar results which confirmed previous studies: after also using linear regression, we found a significant correlation between vitamin D intake and level (p50.04; b50.34) ( Fig. 3) . Several investigations reported that the gene VDR and FOK1 FF genotype with respect to the higher vitamin D consumption reduces the risk of colon cancer (45) , breast cancer (46) , and skin cancer (47) among women. Our study suggests that interactions between FOK1 polymorphism in Iranian obese women and dietary intake of calcium and vitamin D play a major role in bone mineral density and osteoporosis.
Based on the findings from our study, it can be concluded that Iranian obese women with the f allele of FOK1 polymorphism may be more vulnerable to osteoporosis as the ff genotype had significantly lower bone mass compared to the FF genotypes of FOK1. Therefore, this group should pay attention to getting enough calcium and vitamin D. Besides, they should be checked for deficiency complications such as osteoporosis or related cancers. On the other hand, f allele carrier women must avoid risk factors of calcium as well as vitamin D deficiency and osteoporosis, as a consequence. The main limitation of the present study was the relatively small number of subjects in the sample. Further clinical trials, as well as cohort studiess are warranted to address the interactions between FOK1 polymorphism and diet.
